This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
More than 600 pharmaceutical brands now use DeepIntent to simplify campaign planning, activation, meas. Adding more than 100 employees to its team in 2022, the company’s growth has outpaced growth in the broader healthcare advertising segment, as pharmaceutical marketers increasingly embrace digital advertising, particularly on CTV.
Matterkind uses DeepIntent Outcomes’ patented technology to improve audience quality and script performance. As the agency of record for the provider and patient sides of the business, Matterkind used script optimization and a mix of connected TV (CTV), online video, and display ads to reach audiences.
For brands going down this route, the classic approach involves forming an internal agency-style trading desk and equipping them with a demandsideplatform (DSP). Uncovering new audience targeting opportunities. Storing both historical and current campaign data in one centralized platform.
An Example of the All-In Set Up For brands going down this route, the classic approach involves forming an internal agency-style trading desk and equipping them with a demandsideplatform (DSP). The hybrid option alleviates that pressure and empowers brands to take whatever baby steps they want.
Top Stories The Trade Desk’s Share Price Slides as Ad Demand Stutters Demandsideplatform The Trade Desk saw its share price fall by nearly 30 percent after the company said it’s seen a slowdown in ad demand on its platform in its Q3 earnings.
This partnership is part of our continuing strategic approach to maximise reach and viewing opportunities for audiences, wherever they choose to watch, alongside the successful and thriving ITVX, and our market leading commercial TV channels,” said Kevin Lygo, Managing Director, ITV Media and Entertainment. .
Combining AI with programmatic advertising is revolutionizing the way brands and advertisers target their audiences and optimize their campaigns. Pfizer introduces its own generative AI to aid its advertising Pharmaceutical giant Pfizer introduced its own generative AI platform called “Charlie” in early 2024.
Restrictions on pharmaceutical ads look likely, says Madison and Wall’s CEO, CFA and principal Brian Wieser. And this would hit TV particularly hard, since pharmaceutical companies invest heavily in TV. million viewers, thats the biggest sporting audience of the year. Kennedy as his health secretary. M&W forecasts a 6.1
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content